Results 191 to 200 of about 93,643 (333)
Complement dysregulation in human tauopathies
Complement protein and activation product levels were assessed in post‐mortem frontal cortex from three distinct subtypes of Tauopathy: Corticobasal degeneration, globular glial tauopathy, and Pick's disease. Quantification of complement proteins by immunohistochemistry and ELISA showed elevation of key complement proteins (C1q) regulators (FI) and ...
Jacqui Nimmo+3 more
wiley +1 more source
International approaches to frontotemporal dementia diagnosis: From social cognition to neuropsychology [PDF]
Bruce L. Miller+5 more
openalex +1 more source
Abstract INTRODUCTION Few African American (AA) donors have been included in post mortem Alzheimer's disease (AD) studies compared to European‐ancestry (EA) individuals. METHODS We generated transcriptome‐wide bulk pre‐frontal cortex (PFC) gene expression data from 125 AA donors with neuropathologically determined AD and 82 AA controls.
Mark W. Logue+25 more
wiley +1 more source
Tau Protein in Frontotemporal Dementia Linked to Chromosome 3 (FTD-3) [PDF]
Despina Yancopoulou+5 more
openalex +1 more source
Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes. [PDF]
Johnson JCS+8 more
europepmc +1 more source
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory [PDF]
et al,, Fagan, Anne M, Jerome, Gina
core +1 more source
Sex differences in vulnerability to tau pathology: Impact on cognitive decline
Abstract INTRODUCTION Although the link between the presence of amyloid and tau pathologies, neurodegeneration, and cognitive decline in aging individuals is established, it is less clear whether there are sex differences in vulnerability to these pathologies.
Yashar Zeighami+2 more
wiley +1 more source
Familial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics [PDF]
Vivianna M. Van Deerlin+4 more
openalex +1 more source
Striatal dopaminergic patterns and clinical features in frontotemporal dementia. [PDF]
Urso D+10 more
europepmc +1 more source
White matter hyperintensities precede other biomarkers in GRN frontotemporal dementia
Abstract INTRODUCTION Increased white matter hyperintensities (WMHs) have been reported in genetic frontotemporal dementia (FTD) in small studies, but the sequence of WMH abnormalities relative to other biomarkers is unclear. METHODS Using a large dataset (n = 763 GENFI2 participants), we measured WMHs and examined them across genetic FTD variants and ...
Mahdie Soltaninejad+38 more
wiley +1 more source